The Medicare Advantage and Part D programs are a success when measured on metrics such as marketplace competition, consumer satisfaction and quality of care, but could be improved in a number of areas as part of continuous efforts to advance health care quality, health outcomes and health system efficiency, AHA Executive Vice President Tom Nickels told the Centers for Medicare & Medicaid Services yesterday in response to the agency’s request for information on how the programs might be improved. Specifically, AHA encouraged the agency to clarify program guidance for plans and providers in a timely manner; pay quality bonus payments irrespective of the benchmark cap; expand access to telehealth services; and allow plans to adapt benefits to the unique needs of some enrollees. In addition, AHA supports allowing plans to offer non-medical social services; adjusting the Hierarchical Condition Categories for sociodemographic factors; integrating hospice services; and extending access to special needs plans. The letter also offers policy recommendations to address high and rising prices for Part D drugs.

Related News Articles

Headline
Rep. Brett Guthrie, R-Ky., today addressed attendees of AHA’s 2024 Annual Membership Meeting and touched on many of the biggest issues in health care:…
Headline
The Change Healthcare cyberattack was a significant event that caught many off guard, said the Centers for Medicare & Medicaid Services Administrator…
Headline
The voluntary Episode Quality Improvement Program for specialist physicians saved Medicare $20 million in its first year, the Maryland Health Services Cost…
Headline
Commenting April 12 on a proposed rule to strengthen oversight of accrediting organizations, AHA told the Centers for Medicare & Medicaid Services it…
Headline
For future public health emergencies, the Centers for Medicare & Medicaid Services should improve how it sets Medicare rates for clinical diagnostic…
Headline
The Centers for Medicare & Medicaid Services April 4 finalized changes to the Medicare Advantage and prescription drug programs for contract year 2025…